Thomas A. MCCOURT - Jan 17, 2025 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Jan 17, 2025
Transactions value $
$0
Form type
4
Date filed
1/22/2025, 04:35 PM
Previous filing
Jun 17, 2024
Next filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +147K +12.79% $0.00 1.3M Jan 17, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 8, 2022. The earned PSUs were certified and vested on January 17, 2025.
F2 The reporting person acquired 2,014 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2024.